Gsa Capital Partners LLP Cardiovascular Systems Inc Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$12.74 - $15.12 $15,326 - $18,189	-1,203 Reduced 1.29%	91,959 $1.25 Million
Q3 2022 Nov 14, 2022	BUY	$12.93 - $17.17 $712,585 - $946,255	55,111 Added 144.83%	93,162 $1.29 Million
Q2 2022 Aug 09, 2022	SELL	$13.53 - $23.34 $411,758 - $710,306	-30,433 Reduced 44.44%	38,051 $546,000
Q1 2022 May 11, 2022	BUY	$16.14 - $22.6 $628,878 - $880,586	38,964 Added 131.99%	68,484 $1.55 Million
Q4 2021 Feb 14, 2022	BUY	$18.64 - $36.77 $550,252 - $1.09 Million	29,520 New	29,520 $554,000
Q3 2021 Nov 12, 2021	SELL	$32.83 - $43.0 $949,410 - $1.24 Million	-28,919 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$34.41 - $44.03 $489,310 - $626,106	14,220 Added 96.74%	28,919 $1.23 Million
Q1 2021 May 10, 2021	BUY	$37.29 - $47.19 $123,914 - $156,812	3,323 Added 29.21%	14,699 $564,000
Q4 2020 Feb 03, 2021	BUY	$34.3 - $44.09 $125,983 - $161,942	3,673 Added 47.68%	11,376 $498,000
Q3 2020 Nov 06, 2020	BUY	$27.86 - $39.35 $214,605 - $303,113	7,703 New	7,703 $303,000
Q3 2019 Nov 12, 2019	SELL	$42.06 - $51.64 $816,763 - $1 Million	-19,419 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$33.93 - $43.66 $61,074 - $78,588	-1,800 Reduced 8.48%	19,419 $834,000
Q1 2019 May 15, 2019	BUY	$26.74 - $41.32 $567,396 - $876,769	21,219 New	21,219 $820,000
Q4 2018 Feb 12, 2019	SELL	$25.26 - $38.43 $1.21 Million - $1.85 Million	-48,075 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$33.27 - $39.25 $1.6 Million - $1.89 Million	48,075 New	48,075 $1.88 Million
Q4 2017 Feb 14, 2018	SELL	$23.37 - $29.26 $373,218 - $467,282	-15,970 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$27.25 - $31.55 $435,182 - $503,853	15,970	15,970 $450,000

Others Institutions Holding CSII

# of Institutions

Shares Held

35.5K

Call Options Held

Put Options Held

View Full List

About Cardiovascular Systems Inc

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

More about CSII

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account